Synonimy:4-[(3-endo)-3-Hydroksy-8-azabicyklo[3.2.1]ok-8-yl]naftaleno-1-karbonitryl;AC-262536;AC-262,356;4-(3-endo-hydroksy-8-azabicyklo[3.2.1]ok-8-yl)naftaleno-1-karbonitryl
Inne nazwy: AC-262 356/AC-262,356 Sarms/AC-262356
CAS:870888-46-3
MF:C18H18N2O
storage temp. 2-8°C
AC-262,536 is a drug which acts as a selective androgen receptor modulator. Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a Ki of 5nM, and no significant affinity for any other receptors tested. In animal studies it produced a maximal effect of around 66% of the anabolic action of test osterone, but only around 27% of its potency as an androgen.
AC-262536 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator (SARM).
Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a Ki of 5nM, and no significant affinity for any other receptors tested. In animal studies it produced a maximal effect of around 66% of the anabolic action of testosterone, but only around 27% of its potency as an androgen.
1.helping improve the function of the hippocampus (which could stave off the onset of Alzheimer’s disease)
and the possible prevention of prostate cancer. Tests data reveal that this SARM can suppress the activity of dihydroxytestosterone (DHT) in the human prostate cancer cell.
2.Scientists also found out that AC-262,536’s effects in keeping the prostate’s ideal size were 14x weaker than that of testosterone.
3.Acts On Pituitary Function
4.Helps With Muscle Growth
5.May Help With Alzheimer’s Disease
Now while AC-262536 is still considered as a research chemical, there are already people who use it for performance and strength-enhancing purposes.
It is reported that the typical dose of this SARM is about 10 do 30 milligrams per day.
